Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma
MiRNA-146a-5p and miRNA-221-3p, particularly the former, could be valuable diagnostic biomarkers for PTCs. They also seem to be effective in monitoring disease progression during patient follow-up by evaluating their fold change, even when thyroglobulin is uninformative.
Authors
- Luciano Giacomelli (ORCID: https://orcid.org/0000-0003-3598-7522)
- Antonella Verrienti (ORCID: https://orcid.org/0000-0002-3603-5972)
- Giorgio Grani (ORCID: https://orcid.org/0000-0002-0388-1283)
- Sébastiano Filetti (ORCID: https://orcid.org/0000-0001-8570-6448)
- Valeria Del Gatto (ORCID: https://orcid.org/0000-0002-5263-5310)
- Marco Biffoni (ORCID: https://orcid.org/0000-0002-7905-0881)
- Cosimo Durante (ORCID: https://orcid.org/0000-0002-1791-5915)
- Valeria Pecce (ORCID: https://orcid.org/0000-0002-5693-2988)
- Marialuisa Sponziello (ORCID: https://orcid.org/0000-0003-0736-1047)
- Marianna Maranghi (ORCID: https://orcid.org/0000-0002-3117-7488)
- Cira Di Gioia (ORCID: https://orcid.org/0000-0003-4696-0560)
- Samuele Barp
Institutions
- Policlinico Umberto I (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Endocrinological Investigation
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1007/s40618-024-02467-3
- Citations
- 11
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Sapienza Università di Roma